Pulling SEC filings + quote and writing the call…

Avalon GloboCare Corp.
Next earnings Aug 12, 2026
Revenue fell -100.0% YoY.
Revenue (FY2025) $0.00 · FY2025
Avalon GloboCare Corp. shows $0.00 in FY2025 revenue (-100.0% YoY), and -197.8% ROE.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.39M | $1.20M | $1.26M | $1.33M | $0.00 |
| Gross profit | $415K | $273K | — | — | — |
| Operating income | -$8.83M | -$8.79M | -$15.8M | -$4.84M | -$7.59M |
| Net income | -$9.09M | -$11.9M | -$16.7M | -$7.90M | -$18.3M |
| Diluted EPS | -$1.07 | -$1.28 | -$23.80 | -$8.44 | -$5.64 |
| Net margin | -653.5% | -992.4% | -1330.5% | -592.7% | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001630212, latest 10-Q filed 2026-05-11) · EODHD · as of 6/23/2026, 12:42:40 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2022-08-05 | Lu Wenzhao Director | Award | 449K @ $0.78 | $350K |
| 2022-07-18 | Lu Wenzhao Director | Award | 4.44M @ $0.65 | $2.89M |
| 2021-12-21 | Lu Wenzhao Director | Award | 2.40M @ $1.25 | $3.00M |
| 2020-04-01 | Lu Wenzhao Director | Buy | 645K @ $1.55 | $1000K |
1043 tracked peers · median